CareDx announced a transformative year in 2024, achieving significant revenue growth and a return to profitability. The company reported a 32% year-over-year increase in Q4 revenue to $86.6 million and a 19% increase in full-year revenue to $333.8 million. Net income for Q4 was $87.7 million, a substantial improvement from a net loss in the prior year.
Fourth quarter revenue increased 32% year-over-year to $86.6 million.
Testing services revenue grew 37% year-over-year to $63.8 million, with volume increasing 14%.
GAAP net income for the fourth quarter was $87.7 million, a significant improvement from a net loss in the prior year.
Cash flow from operations for the fourth quarter was $21.9 million, contributing to a strong cash position of $261 million with no debt.
For the full year 2025, CareDx expects revenue to be in the range of $365 million to $375 million and adjusted EBITDA to be in the range of $29 million to $33 million.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance